Consistent with these findings, human correlative studies reveal a poor prognosis and early post-treatment relapse associated with tumor cell IFN-γ-KLF4-SLURP1 and CD200-CD200R1 gene signatures. This evidence concerns the gene CD200 and neoplasm.